Dr. Cornel Stanciu of Dartmouth Health discusses his research on kratom, an herbal supplement that is widely available but carries addiction risks for some users.

While the FDA has classified synthetic kratom as a public health threat and dozens of states have enacted regulations or bans ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...

Living with chronic pain can feel overwhelming, especially when conventional treatments fall short. You've probably heard ...

Takeda Pharmaceutical Co. Ltd. has synthesized heterocyclic compounds acting as orexin OX2 receptor (OX2R; HCRTR2) agonists reported to be useful for the treatment of narcolepsy, among others.

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

New Jersey, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Pinnacle Treatment Centers, a leader in providing evidence-based care for individuals struggling with Substance Use Disorder (SUD), is thrilled to ...

For adults with type 2 diabetes and/or overweight/obesity and high triglycerides, GLP-1RAs are not associated with pancreatitis.

Those who kept taking buprenorphine as prescribed for at least a year were much less likely to suffer an overdose or require ...

Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological ...

Yichang Humanwell Pharmaceutical Co. Ltd. has disclosed morphinan derivatives acting as κ-opioid receptor agonists reported to be useful for the treatment of pain and pruritus.